UPDATE: Cowen Reiterates $150 PT on Novavax (NVAX), Believes 'briefing documents suggest that the vaccine meets all the requirements for approval '
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 11.32 -1.24 (9.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.56 | 52 Week High | $9.23 | |||
| Open | $12.35 | 52 Week Low | $1.16 | |||
| Day High | $13.33 | P/E | N/A | |||
| Day Low | $10.88 | EPS | $-0.30 | |||
| Volume | 19,410,874 | |||||
